{{Rsnum
|rsid=1314913
|Gene=RAD51B
|Chromosome=14
|position=68232877
|Orientation=plus
|GMAF=0.1084
|Gene_s=RAD51B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.9 | 29.2 | 0.9
| HCB | 97.1 | 2.9 | 0.0
| JPT | 93.8 | 5.3 | 0.9
| YRI | 91.2 | 8.8 | 0.0
| ASW | 77.2 | 21.1 | 1.8
| CHB | 97.1 | 2.9 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 67.3 | 31.7 | 1.0
| LWK | 81.8 | 16.4 | 1.8
| MEX | 77.6 | 22.4 | 0.0
| MKK | 59.0 | 37.8 | 3.2
| TSI | 63.7 | 31.4 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23001122
  |Trait=Breast cancer (male)
  |Title=Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.
  |RiskAllele=
  |Pval=3E-13
  |OR=1.57
  |ORtxt=[1.39-1.77]
  |OA=1
}}

{{PMID Auto
|PMID=17903304
|Title=Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.
|OA=1
}}

{{PMID Auto
|PMID=17903306
|Title=Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}